La Canada, CA, United States of America

Eugene Dejuan


Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 576(Granted Patents)


Company Filing History:


Years Active: 2004-2013

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Inventor Eugene Dejuan

Introduction

Eugene Dejuan is a notable inventor based in La Canada, CA (US). He has made significant contributions to the field of intraocular drug delivery, holding a total of 5 patents. His work focuses on developing devices that enhance the delivery of therapeutic agents to challenging areas of the body.

Latest Patents

One of his latest patents is a reservoir device for intraocular drug delivery. This innovative delivery device allows for the sustained release of an agent, particularly useful for therapeutic applications in limited access regions, such as the posterior chamber of the eye and inner ear. The device is designed to be minimally invasive, refillable, and easily fixed to the treatment area. It features a hollow body with an inlet port for agent insertion, a reservoir for holding the agent, and a delivery mechanism for sustained release.

Another significant patent is for devices specifically designed for intraocular drug delivery. These therapeutic agent delivery devices are particularly suitable for administering agents to limited access regions, such as the posterior chamber of the eye and inner ear. The preferred devices are also minimally invasive, refillable, and can be easily affixed to the treatment area. They include a non-linear shaped body member that houses one or more substances and a delivery mechanism for sustained delivery.

Career Highlights

Eugene Dejuan is affiliated with The Johns Hopkins University, where he continues to innovate and contribute to the field of medical technology. His work has the potential to significantly improve patient outcomes in ocular therapies.

Collaborations

Eugene has collaborated with notable colleagues, including Terry Harrison Shelley and Signe Erickson Varner. Their combined expertise enhances the development of advanced therapeutic delivery systems.

Conclusion

Eugene Dejuan's contributions to intraocular drug delivery represent a significant advancement in medical technology. His innovative patents and collaborations continue to pave the way for improved therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…